Letter to the editor
Academic article
-
Arffman, Maare; Meriranta, Leo; Autio, Matias et al. (2024). Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas. (external link)
-
Rekeland, Ingrid Gurvin; Sørland, Kari; Neteland, Lisbeth Lykke et al. (2024). Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (external link)
-
Sandvik, Miriam Kristine; Sørland, Kari; Leirgul, Elisabeth et al. (2023). Endothelial dysfunction in ME/CFS patients. (external link)
-
Isaksen, Kathrine Thuestad; Galleberg, Renate Berget; Mastroianni, Maria Adele et al. (2023). The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy. (external link)
-
Steinsvik, Elisabeth Kjelsvik; Hausken, Trygve; Fluge, Øystein et al. (2023). Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. (external link)
-
Lia, Kjersti; R.K. Jørgensen, Rasmus; Wold, Bente Loftum et al. (2023). Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study. (external link)
-
Bjorland, Line; Mahesparan, Rupavathana; Fluge, Øystein et al. (2023). Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study. (external link)
-
Ueland, Marthe; Hajdarevic, Riad; Mella, Olav et al. (2022). No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). (external link)
-
Smeland, Knut Bjøro; Holte, Harald; Fagerli, Unn-Merete et al. (2022). Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life. (external link)
-
Bjorland, Line; Kurz, Kathinka Dæhli; Fluge, Øystein et al. (2022). Butterfly glioblastoma: Clinical characteristics, treatment strategies and outcomes in a population-based cohort. (external link)
-
Rekeland, Ingrid Gurvin; Sørland, Kari; Bruland, Ove et al. (2022). Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. (external link)
-
Hajdarevic, Riad; Lande, Asgeir; Mehlsen, Jesper et al. (2022). Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci. (external link)
-
Bjorland, Line Sagerup; Fluge, Oystein; Gilje, Bjornar et al. (2021). Treatment approach and survival from glioblastoma: Results from a population-based retrospective cohort study from Western Norway. (external link)
-
Hoel, Fredrik; Hoel, August; Pettersen, Ina Katrine Nitschke et al. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. (external link)
-
Hajdarevic, Riad; Lande, Asgeir; Rekeland, Ingrid Gurvin et al. (2021). Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci. (external link)
-
Sørland, Kari; Sandvik, Miriam Kristine; Rekeland, Ingrid Gurvin et al. (2021). Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention Study. (external link)
-
Meriranta, Leo; Alkodsi, Amjad; Pasanen, Annika et al. (2021). Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. (external link)
-
Leppä, Sirpa; Jørgensen, Judit; Tierens, Anne et al. (2020). Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis. (external link)
-
Lande, Asgeir; Fluge, Øystein; Strand, Elin Bolle et al. (2020). Human Leukocyte Antigen Alleles Associated With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). (external link)
-
Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A et al. (2020). Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress. (external link)
-
Fosså, Alexander; Smeland, Knut Bjøro; Fluge, Øystein et al. (2020). Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue. (external link)
-
Rekeland, Ingrid Gurvin; Fosså, Alexander; Lande, Asgeir et al. (2020). Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study. (external link)
-
Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Fagerli, Unn-Merete et al. (2019). Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. (external link)
-
Fluge, Øystein; Rekeland, Ingrid Gurvin; Lien, Katarina et al. (2019). B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. (external link)
-
Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A et al. (2019). Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation. (external link)
-
Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid et al. (2019). No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. (external link)
-
Pettersen, Ina Katrine Nitschke; Tusubira, Deusdedit; Ashrafi, Hanan et al. (2019). Upregulated PDK4 expression is a sensitive marker of increased fatty acid
oxidation. (external link)
-
Giannoccaro, Maria Pia; Cossins, Judith; Sørland, Kari et al. (2019). Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome. (external link)
-
Simensen, Victoria C; Smeland, Knut Bjøro; Kiserud, Cecilie E. et al. (2019). Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma. (external link)
-
Rekeland, Ingrid Gurvin; Fluge, Øystein; Alme, Kine et al. (2018). Rituximab serum concentrations and anti-rituximab antibodies during B-cell depletion therapy for myalgic encephalopathy/chronic fatigue syndrome. (external link)
-
Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten et al. (2018). Chronic fatigue is highly prevalent in survivors of autologous stem
cell transplantation and associated with IL-6, neuroticism,
cardiorespiratory fitness, and obesity. (external link)
-
Gunther, Oliver P; Gardy, Jennifer L; Stafford, Phillip et al. (2018). Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). (external link)
-
Stensland, Marius; Klos, Jan; Fluge, Øystein et al. (2017). Extranodal NK/T-cell lymphoma, nasal type, primarily involving ovary. (external link)
-
Fluge, Øystein; Mannsåker, Bård; Torp, Anders et al. (2017). Consolidative radiotherapy to residual masses after chemotherapy is associated with improved outcome in diffuse large B-cell lymphoma. A retrospective, population-based study. (external link)
-
Fluge, Øystein; Mella, Olav; Bruland, Ove et al. (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.. (external link)
-
Dale, Jon Espen; Sebjørnsen, Sigrunn; Leh, Sabine Maria et al. (2016). Multimodal therapy is feasible in elderly anal cancer patients. (external link)
-
Fluge, Øystein; Thurmer, Hanne (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. (external link)
-
Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2016). A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. (external link)
-
Loebel, Madlen; Grabowski, Patricia; Heidecke, Harald et al. (2016). Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. (external link)
-
Kiserud, Cecilie E.; Fagerli, Unn-Merete; Smeland, Knut Bjøro et al. (2016). Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. (external link)
-
Lunde, Sigrid; Kristoffersen, Einar Klæboe; Sapkota, Dipak et al. (2016). Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. (external link)
-
Pulczynski, Elisa J.; Kuittinen, Outi; Erlanson, Martin et al. (2015). Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group. (external link)
-
Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2015). Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. (external link)
-
Fluge, Øystein; Risa, Kristin; Lunde, Sigrid et al. (2015). B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. (external link)
-
Taskinen, Minna; Louhimo, Riku; Koivula, Satu et al. (2014). Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma. (external link)
-
Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2013). High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. (external link)
-
Holte, Harald; Leppä, Sirpa; Bjørkholm, Mikaela et al. (2013). Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. (external link)
-
Knudsen-Baas, Kristin Marie; Moen, Gunnar; Fluge, Øystein et al. (2013). Pseudoprogression in high-grade glioma. (external link)
-
Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2013). Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 - 2008. (external link)
-
Myklebust, Mette Pernille; Fluge, Øystein; Immervoll, Heike et al. (2012). Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. (external link)
-
Riihijärvi, Sari; Nurmi, Heidi; Holte, Harald et al. (2012). High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy. (external link)
-
Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H. et al. (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. (external link)
-
Myklebust, Mette Pernille; Bruland, Ove; Fluge, Øystein et al. (2011). MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. (external link)
-
Eide, Marianne Brodtkorb; Lauritzsen, Grete Fossum; Kvalheim, Gunnar et al. (2011). High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. (external link)
-
Fluge, Øystein; Bruland, Ove; Risa, Kristin et al. (2011). Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. (external link)
-
Dresemann, Gregor; Weller, Michael; Rosenthal, Mark A. et al. (2010). Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. (external link)
-
Dahl, Olav; Fluge, Øystein; Carlsen, Erik et al. (2009). Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. (external link)
-
Fluge, Øystein; Gravdal, K; Carlsen, E et al. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. (external link)
-
Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove et al. (2009). Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. (external link)
-
Fluge, Øystein; Mella, Olav (2009). Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. (external link)
-
Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove et al. (2008). Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. (external link)
-
Dahl, Olav; Borkamo, Erling Dahl; Fluge, Øystein (2008). Current status of antivascular therapy and targeted treatment in the clinic. (external link)
-
Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav et al. (2008). Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. (external link)
-
Bruland, Ove; Fluge, Øystein; Immervoll, Heike et al. (2008). Gene expression reveals two distinct groups of anal carcinomas with clinical implications. (external link)
-
Fluge, Øystein; Bruland, Ove; Akslen, Lars A. et al. (2006). Gene expression in poorly differentiated papillary thyroid carcinomas. (external link)
-
Fluge, Øystein; Omenaas, Ernst; Eide, Geir Egil et al. (1998). Fish consumption and respiratory symptoms among young adults in a Norwegian community. (external link)
-
Svanes, Cecilie; Omenaas, Ernst; Eide, Geir Egil et al. (1998). Hospitalization for lung disease in early childhood and asthma symptoms in young adulthood. (external link)
Academic lecture
Academic literature review
-
Steiner, Sophie; Fehrer, Annick; Hoheisel, Friederike et al. (2023). Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center. (external link)
-
Fluge, Øystein; Tronstad, Karl Johan; Mella, Olav (2021). Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). (external link)
-
Dahl, Olav; Fluge, Øystein (2008). Analkreft. (external link)
Academic commentary
Reader opinion piece
Chapter
Abstract
-
Leppä, Sirpa; Taskinen, Minna; Koivula, Satu et al. (2012). Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma. (external link)
-
Holte, Harald; Bogsrud, Trond; Leppa, S. et al. (2011). (18)FDG PET/CT AFTER INTENSIFIED CHEMO-IMMUNOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AGED 18-65 YEARS WITH AAIPI 2-3. POSITIVE OR INDETERMINATE LESIONS HAVE A LOW POSITIVE PREDICTIVE VALUE. A NORDIC PHASE II SUBSTUDY. (external link)
-
Koivula, Satu; Taskinen, Minna; Chen, Ping et al. (2010). Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. (external link)
-
Riihijärvi, Sari; Nyman, Heidi; Holte, Harald et al. (2010). High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Dose-Dense Chemoimmunotherapy and Systemic CNS Prophylaxis. Results From a Nordic Phase II Study. (external link)
-
Holte, Harald; Leppä, Sirpa; Björkholm, Magnus et al. (2010). R-CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years. (external link)
-
Koivula, Satu; Taskinen, Minna; Chen, Ping et al. (2010). Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. (external link)
Academic chapter/article/Conference paper
Doctoral dissertation
See a complete overview of publications in Cristin.